Israel Englander Verona Pharma PLC Transaction History

Millennium Management LLC

$213 Billion
Q3 2025

A detailed history of Israel Englander (Millennium Management LLC) transactions in Verona Pharma PLC stock. As of the latest transaction made, Millennium Management LLC holds 1,796,738 shares of VRNA stock, worth $192 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

1,796,738

Previous 377,168 376.38%

Holding current value

$192 Million

Previous $35.7 Million 437.33%

% of portfolio

0.09%

Previous 0.02%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 14, 2025	BUY	$90.08 - $106.69 $128 Million - $151 Million	1,419,570 Added 376.38%	1,796,738 $192 Million
Q2 2025 Aug 14, 2025	BUY	$53.9 - $98.68 $2.89 Million - $5.29 Million	53,623 Added 16.57%	377,168 $35.7 Million
Q1 2025 May 15, 2025	BUY	$44.81 - $69.63 $6.82 Million - $10.6 Million	152,097 Added 88.71%	323,545 $20.5 Million
Q4 2024 Feb 14, 2025	BUY	$28.71 - $47.02 $328,499 - $538,002	11,442 Added 7.15%	171,448 $7.96 Million
Q3 2024 Nov 14, 2024	SELL	$15.46 - $30.16 $5.68 Million - $11.1 Million	-367,634 Reduced 69.68%	160,006 $4.6 Million

Q2 2024 Aug 14, 2024	BUY	$11.48 - $17.02 $270,549 - $401,110	23,567 Added 4.68%	527,640 $7.63 Million
Q1 2024 May 15, 2024	BUY	$15.3 - $20.24 $1.85 Million - $2.44 Million	120,722 Added 31.49%	504,073 $8.11 Million
Q4 2023 Feb 14, 2024	SELL	$11.94 - $20.47 $1.79 Million - $3.07 Million	-150,133 Reduced 28.14%	383,351 $7.62 Million
Q2 2023 Aug 14, 2023	SELL	$19.41 - $23.43 $335,365 - $404,823	-17,278 Reduced 3.14%	533,484 $11.3 Million
Q1 2023 May 15, 2023	BUY	$18.06 - $25.27 $4.27 Million - $5.98 Million	236,709 Added 75.37%	550,762 $11.1 Million
Q4 2022 Feb 14, 2023	BUY	$9.84 - $26.13 $2.31 Million - $6.13 Million	234,713 Added 295.83%	314,053 $8.21 Million
Q3 2022 Nov 14, 2022	BUY	$4.14 - $13.59 $328,467 - $1.08 Million	79,340 New	79,340 $811,000
Q2 2022 Aug 15, 2022	SELL	$3.55 - $5.06 $95,136 - $135,602	-26,799 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$4.82 - $6.98 $52,200 - $75,593	10,830 Added 67.82%	26,799 $134,000
Q4 2021 Feb 14, 2022	BUY	$3.91 - $7.08 $4,625 - $8,375	1,183 Added 8.0%	15,969 $107,000
Q3 2021 Nov 15, 2021	BUY	$5.29 - $6.35 $78,217 - $93,891	14,786 New	14,786 $81,000
Q4 2020 Feb 16, 2021	SELL	$5.51 - $8.11 $60,290 - $88,739	-10,942 Closed	0 $0
Q3 2020 Nov 16, 2020	BUY	$4.45 - $10.2 $48,691 - $111,608	10,942 New	10,942 $68,000

Others Institutions Holding VRNA

# of Institutions

275

Shares Held

77.1M

Call Options Held

686K

Put Options Held

442K

View Full List

About Verona Pharma plc

Ticker VRNA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,954,200
Market Cap $6.52B
Description
Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodi...

More about VRNA

Track Israel Englander's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.

Account